A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis

Alton, EW; Armstrong, DK; Ashby, D; Bayfield, KJ; Bilton, D; Bloomfield, EV; Boyd, AC; ... Wolstenholme-Hogg, P; + view all Alton, EW; Armstrong, DK; Ashby, D; Bayfield, KJ; Bilton, D; Bloomfield, EV; Boyd, AC; Brand, J; Buchan, R; Calcedo, R; Carvelli, P; Chan, M; Cheng, SH; Collie, DS; Cunningham, S; Davidson, HE; Davies, G; Davies, JC; Davies, LA; Dewar, MH; Doherty, A; Donovan, J; Dwyer, NS; Elgmati, HI; Featherstone, RF; Gavino, J; Gea-Sorli, S; Geddes, DM; Gibson, JS; Gill, DR; Greening, AP; Griesenbach, U; Hansell, DM; Harman, K; Higgins, TE; Hodges, SL; Hyde, SC; Hyndman, L; Innes, JA; Jacob, J; Jones, N; Keogh, BF; Limberis, MP; Lloyd-Evans, P; Maclean, AW; Manvell, MC; McCormick, D; McGovern, M; McLachlan, G; Meng, C; Montero, MA; Milligan, H; Moyce, LJ; Murray, GD; Nicholson, AG; Osadolor, T; Parra-Leiton, J; Porteous, DJ; Pringle, IA; Punch, EK; Pytel, KM; Quittner, AL; Rivellini, G; Saunders, CJ; Scheule, RK; Sheard, S; Simmonds, NJ; Smith, K; Smith, SN; Soussi, N; Soussi, S; Spearing, EJ; Stevenson, BJ; Sumner-Jones, SG; Turkkila, M; Ureta, RP; Waller, MD; Wasowicz, MY; Wilson, JM; Wolstenholme-Hogg, P; - view fewer (2016) A randomised, double-blind, placebo-controlled trial of repeated nebulisation of non-viral cystic fibrosis transmembrane conductance regulator (CFTR) gene therapy in patients with cystic fibrosis. Efficacy and Mechanism Evaluation , 3 (5) pp. 1-210. 10.3310/eme03050 . Green open access

http://ift.tt/2GerLC4